Live birth rates after IVF are reduced by both low and high progesterone levels on the day of human chorionic gonadotrophin administration

Human Reproduction

Volumn 29, Issue 8, 2014, Pages 1698-1705

  Santos Ribeiro, S ^a,b   Polyzos, N P ^a   Haentjens, P ^a   Smitz, J ^a   Camus, M ^a   Tournaye, H ^a   Blockeel, C ^a  

^a CENTRE FOR REPRODUCTIVE MEDICINE   (Belgium)

^b HOSPITAL DE SANTA MARIA   (Portugal)

Author keywords

In vitro fertilization; Live birth rate; Ovarian stimulation; Progesterone

Indexed keywords

CHORIONIC GONADOTROPIN; PROGESTERONE;

ADULT; ARTICLE; BIRTH RATE; DOWN REGULATION; EMBRYO TRANSFER; FEMALE; FERTILIZATION IN VITRO; FOLLICULAR PHASE; HUMAN; LIVE BIRTH; MAJOR CLINICAL STUDY; OOCYTE MATURATION; OOCYTE RETRIEVAL; PROGESTERONE BLOOD LEVEL; BLOOD; OVULATION INDUCTION; PREGNANCY; PREGNANCY RATE; RETROSPECTIVE STUDY;

ADULT; CHORIONIC GONADOTROPIN; EMBRYO TRANSFER; FEMALE; FERTILIZATION IN VITRO; HUMANS; LIVE BIRTH; OVULATION INDUCTION; PREGNANCY; PREGNANCY RATE; PROGESTERONE; RETROSPECTIVE STUDIES;

EID: 84904345803     PISSN: 02681161     EISSN: 14602350     Source Type: Journal    
DOI: 10.1093/humrep/deu151     Document Type: Article

References (75)

1. Abuzeid MI, Sasy MA. Elevated progesterone levels in the late follicular phase do not predict success of in vitro fertilization-embryo transfer. Fertil Steril 1996;65:981-985.
2. Al-Azemi M, Kyrou D, Kolibianakis EM, Humaidan P, Van Vaerenbergh I, Devroey P, Fatemi HM. Elevated progesterone during ovarian stimulation for IVF. Reprod Biomed Online 2012;24:381-388.
3. Barile G, Sica G, Montemurro A, Iacobelli S, Corradini M. Levels of estrogen and progesterone receptor in human endometrium during the menstrual cycle. Eur J Obstet Gynecol Reprod Biol 1979;9:243-246.
4. Batten BE, Roh SI, Kim MH. The effects of the progesterone antagonist RU-486 on mouse preimplantation development in vitro and in vivo. Contraception 1988;38:365-371.
5. Blockeel C, De Vos M, VerpoestW, Stoop D, Haentjens P, Devroey P. Can 200 IU of hCG replace recombinant FSH in the late follicular phase in a GnRH-antagonist cycle? A pilot study. Hum Reprod 2009;24:2910-2916.
6. Borman SM, Chaffin CL, Schwinof KM, Stouffer RL, Zelinski-Wooten MB. Progesterone promotes oocyte maturation, but not ovulation, in nonhuman primate follicles without a gonadotropin surge. Biol Reprod 2004;71:366-373.
7. Bosch E. Comment on: is progesterone elevation on the day of human chorionic gonadotrophin administration associated with the probability of pregnancy in in vitro fertilization? A systematic review and meta-analysis. Hum Reprod Update 2008;14:194-195; author reply 195-196.
8. Bosch E. Reply: elevated P level on the day of hCGadministration is related to FSH dose: is it the whole truth? Hum Reprod 2011;26:499-500.
9. Bosch E, Valencia I, Escudero E, Crespo J, Simon C, Remohi J, Pellicer A. Premature luteinization during gonadotropin-releasing hormone antagonist cycles and its relationship with in vitro fertilization outcome. Fertil Steril 2003;80:1444-1449.
10. Bosch E, Labarta E, Crespo J, Simon C, Remohi J, Jenkins J, Pellicer A. Circulating progesterone levels and ongoing pregnancy rates in controlled ovarian stimulation cycles for in vitro fertilization: analysis of over 4000 cycles. Hum Reprod 2010;25:2092-2100.
11. Bridges PJ, Komar CM, Fortune JE. Gonadotropin-induced expression of messenger ribonucleic acid for cyclooxygenase-2 and production of prostaglandins E and F2alpha in bovine preovulatory follicles are regulated by the progesterone receptor. Endocrinology 2006;147:4713-4722.
12. Bustillo M, Stern JJ, Coulam CB. Serum progesterone at the time of human chorionic gonadotrophin does not predict pregnancy in in-vitro fertilization and embryo transfer. Hum Reprod 1995;10:2862-2867.
13. Chaffkin LM, Luciano AA, Peluso JJ. Progesterone as an autocrine/paracrine regulator of human granulosa-cell proliferation. J Clin Endocr Metab 1992; 75:1404-1408.
14. Check JH, Lurie D, Askari HA, Hoover L, Lauer C. The range of subtle rise in serum progesterone levels following controlled ovarian hyperstimulation associated with lower in vitro fertilization pregnancy rates is determined by the source of manufacturer. Eur J Obstet Gynecol Reprod Biol 1993; 52:205-209.
15. Check JH, Hourani C, Choe JK, Callan C, Adelson HG. Pregnancy rates in donors versus recipients according to the serum progesterone level at the time of human chorionic gonadotropin in a shared oocyte program. Fertil Steril 1994;61:262-264.
16. Chetkowski RJ, Kiltz RJ, Salyer WR. In premature luteinization, progesterone induces secretory transformation of the endometrium without impairment of embryo viability. Fertil Steril 1997;68:292-297.
17. Collins RL, Hodgen GD. Blockade of the spontaneous midcycle gonadotropin surge in monkeys by RU 486: a progesterone antagonist or agonist? J Clin Endocrinol Metab 1986;63:1270-1276.
18. Couzinet B, Brailly S, Bouchard P, Schaison G. Progesterone stimulates luteinizing-hormone secretion by acting directly on the pituitary. J Clin Endocr Metab 1992;74:374-378.
19. De Geyter C, De Geyter M, Huber PR, Nieschlag E, Holzgreve W. Progesterone serum levels during the follicular phase of the menstrual cycle originate from the crosstalk between the ovaries and the adrenal cortex. Hum Reprod 2002;17:933-939.
20. de Ziegler D, Bijaoui G, Chapron C. Pre-hCG elevation of plasma progesterone: good, bad or otherwise. Hum Reprod Update 2008;14:393.
21. Dirnfeld M, Goldman S, Gonen Y, Koifman M, Lissak A, Abramovici H. A modest increase in serum progesterone levels on the day of human chorionic gonadotropin (hCG) administration may influence pregnancy rate and pregnancy loss in in vitro fertilization-embryo transfer (IVF-ET) patients. J Assist Reprod Genet 1993;10:126-129.
22. Doldi N, Marsiglio E, Destefani A, Gessi A, Merati G, Ferrari A. Elevated serum progesterone on the day of HCG administration in IVF is associated with a higher pregnancy rate in polycystic ovary syndrome. Hum Reprod 1999;14:601-605.
23. Edelstein MC, Seltman HJ, Cox BJ, Robinson SM, Shaw RA, Muasher SJ. Progesterone levels on the day of human chorionic gonadotropin administration in cycles with gonadotropin-releasing hormone agonist suppression are not predictive of pregnancy outcome. Fertil Steril 1990; 54:853-857.
24. Elnashar AM. Progesterone rise on the day of HCG administration (premature luteinization) in IVF: an overdue update. J Assist Reprod Genet 2010;27:149-155.
25. Fanchin R, de Ziegler D, Taieb J, Hazout A, Frydman R. Premature elevation of plasma progesterone alters pregnancy rates of in vitro fertilization and embryo transfer. Fertil Steril 1993;59:1090-1094.
26. Fanchin R, Righini C, Olivennes F, de Ziegler D, Selva J, Frydman R. Premature progesterone elevation does not alter oocyte quality in in vitro fertilization. Fertil Steril 1996;65:1178-1183.
27. Fanchin R, Hourvitz A, Olivennes F, Taieb J, Hazout A, Frydman R. Premature progesterone elevation spares blastulation but not pregnancy rates in in vitro fertilization with coculture. Fertil Steril 1997a;68:648-652.
28. Fanchin R, Righini C, Olivennes F, Ferreira AL, de Ziegler D, Frydman R. Consequences of premature progesterone elevation on the outcome of in vitro fertilization: insights into a controversy. Fertil Steril 1997b;68:799-805.
29. Felberbaum R, Diedrich K. Ovarian stimulation for in-vitro fertilization/ intracytoplasmic sperm injection with gonadotrophins and gonadotrophinreleasing hormone analogues: agonists and antagonists. Hum Reprod 1999; 14(Suppl. 1):207-221.
30. Feldberg D, Goldman GA, Ashkenazi J, Dicker D, Shelef M, Goldman JA. The impact of high progesterone levels in the follicular phase of in vitro fertilization (IVF) cycles: a comparative study. J in Vitro Fert Embryo Transf 1989;6:11-14.
31. Filicori M,Cognigni GE, Gamberini E, Parmegiani L, Troilo E, Roset B. Efficacy of low-dose human chorionic gonadotropin alone to complete controlled ovarian stimulation. Fertil Steril 2005;84:394-401.
32. Fleming R. Progesterone elevation on the day of hCG: methodological issues. Hum Reprod Update 2008;14:391-392.
33. Givens CR, Schriock ED, Dandekar PV, Martin MC. Elevated serum progesterone levels on the day of human chorionic gonadotropin administration do not predict outcome in assisted reproduction cycles. Fertil Steril 1994;62:1011-1017.
34. Harada T, Yoshida S, Katagiri C, Takao N, Ikenari T, Toda T, Mio Y, Terakawa N. Reduced implantation rate associated with a subtle rise in serum progesterone concentration during the follicular phase of cycles stimulated with a combination of a gonadotrophin-releasing hormone agonist and gonadotrophin. Hum Reprod 1995;10:1060-1064.
35. Harada T, Katagiri C, Takao N, Toda T, Mio Y, Terakawa N. Altering the timing of human chorionic gonadotropin injection according to serum progesterone (P) concentrations improves embryo quality in cycles with subtle P rise. Fertil Steril 1996;65:594-597.
36. Hibbert ML, Stouffer RL, Wolf DP, Zelinski-Wooten MB. Midcycle administration of a progesterone synthesis inhibitor prevents ovulation in primates. Proc Natl Acad Sci USA 1996;93:1897-1901.
37. Hild-Petito S, Stouffer RL, Brenner RM. Immunocytochemical localization of estradiol and progesterone receptors in the monkey ovary throughout the menstrual cycle. Endocrinology 1988;123:2896-2905.
38. Hofmann GE, Khoury J, Johnson CA, Thie J, Scott RT Jr. Premature luteinization during controlled ovarian hyperstimulation for in vitro fertilization-embryo transfer has no impact on pregnancy outcome. Fertil Steril 1996;66:980-986.
39. Huang JC, Jackson KV, Hornstein MD, Ginsburg ES. The effect of elevated serum progesterone during ovulation induction in in vitro fertilizationembryo transfer. J Assist Reprod Genet 1996;13:617-624.
40. Ioannidis G, Sacks G, Reddy N, Seyani L,Margara R, Lavery S, TrewG. Day 14 maternal serumprogesterone levels predict pregnancy outcome in IVF/ICSI treatment cycles: a prospective study. Hum Reprod 2005;20:741-746.
41. Kilicdag EB, Haydardedeoglu B, Cok T, Hacivelioglu SO, Bagis T. Premature progesterone elevation impairs implantation and live birth rates in GnRH-agonist IVF/ICSI cycles. Arch Gynecol Obstet 2010;281:747-752.
42. Kolibianakis EM, Venetis CA, Bontis J, Tarlatzis BC. Significantly lower pregnancy rates in the presence of progesterone elevation in patients treated with GnRH antagonists and gonadotrophins: a systematic review and meta-analysis. Curr Pharm Biotechnol 2012;13:464-470.
43. Labarta E, Martinez-Conejero JA, Alama P, Horcajadas JA, Pellicer A, Simon C, Bosch E. Endometrial receptivity is affected in women with high circulating progesterone levels at the end of the follicular phase: a functional genomics analysis. Hum Reprod 2011;26:1813-1825.
44. Legro RS, Ary BA, Paulson RJ, Stanczyk FZ, SauerMV. Premature luteinization as detected by elevated serum progesterone is associated with a higher pregnancy rate in donor oocyte in-vitro fertilization. Hum Reprod 1993; 8:1506-1511.
45. Lessey BA, Killam AP, Metzger DA, Haney AF, Greene GL, McCarty KS Jr. Immunohistochemical analysis of human uterine estrogen and progesterone receptors throughout the menstrual cycle. J Clin Endocrinol Metab 1988;67:334-340.
46. Levy MJ, Smotrich DB, Widra EA, Sagoskin AW, Murray DL, Hall JL. The predictive value of serum progesterone and 17-OH progesterone levels on in-vitro fertilization outcome. J Assist Reprod Genet 1995;12:161-166.
47. Li R, Qiao J,Wang L, Zhen X, Lu Y. Serum progesterone concentration on day of HCG administration and IVF outcome. Reprod Biomed Online 2008;16:627-631.
48. Luke B, Brown MB,Wantman E, Lederman A, GibbonsW, Schattman GL, Lobo RA, Leach RE, Stern JE. Cumulative birth rates with linked assisted reproductive technology cycles. New Engl J Med 2012;366:2483-2491.
49. Malizia BA, Hacker MR, Penzias AS. Cumulative live-birth rates after in vitro fertilization. New Engl J Med 2009;360:236-243.
50. Martinez F, Coroleu B, Clua E, Tur R, Buxaderas R, Parera N, Barri PN, Balasch J. Serum progesterone concentrations on the day of HCG administration cannot predict pregnancy in assisted reproduction cycles. Reprod Biomed Online 2004;8:183-190.
51. Melo MA, Meseguer M, Garrido N, Bosch E, Pellicer A, Remohi J. The significance of premature luteinization in an oocyte-donation programme. Hum Reprod 2006;21:1503-1507.
52. Miller KF, Behnke EJ, Arciaga RL, Goldberg JM, ChinNW, Awadalla SG. The significance of elevated progesterone at the time of administration of human chorionic gonadotropin may be related to luteal support. J Assist Reprod Genet 1996;13:698-701.
53. Mio Y, Sekijima A, Iwabe T, Onohara Y, Harada T, Terakawa N. Subtle rise in serum progesterone during the follicular phase as a predictor of the outcome of in vitro fertilization. Fertil Steril 1992;58:159-166.
54. Moffitt DV, Queenan JT Jr, Shaw R, Muasher SJ. Progesterone levels on the day of human chorionic gonadotropin do not predict pregnancy outcome from the transfer of fresh or cryopreserved embryos from the same cohort. Fertil Steril 1997;67:296-301.
55. Natraj U, Richards JS. Hormonal regulation, localization, and functional activity of the progesterone receptor in granulosa cells of rat preovulatory follicles. Endocrinology 1993;133:761-769.
56. OzcakirHT, Levi R, Tavmergen E, GokerEN. Premature luteinization defined as progesterone estradiol ratio .1 on hCG administration day seems to adversely affect clinical outcome in long gonadotropin-releasing hormone agonist cycles. J Obst Gynaecol Res 2004a;30:100-104.
57. Ozcakir HT, Levi R, Tavmergen E, Goker ENT. Premature luteinization defined as progesterone estradiol ratio. 1 on hCG administration day seems to adversely affect clinical outcome in long gonadotropinreleasing hormone agonist cycles. J Obstet Gynaecol Res 2004b;30: 100-104.
58. Randall GW, Gantt PC, Ganti D, Kirk MJ, Romines N. Elevated serum progesterone values at the time of ovulation induction in luteal leuprolide acetate-down-regulated GIFT cycles are associated with decreased clinical pregnancy rates. J Assist Reprod Genet 1996;13: 459-463.
59. Ravn V, Rasmussen BB, Hojholt L, Barfoed M, Heiberg I, Svenstrup B, Thorpe SM. Estrogen-and progesterone receptors in normal cycling endometrium as studied by end-point titration. Cell Tissue Res 1994; 276:419-428.
60. Saleh HA, Omran MS, Draz M. Does subtle progesterone rise on the day of HCG affect pregnancy rate in long agonist ICSI cycles? J Assist Reprod Genet 2009;26:239-242.
61. SchoolcraftW, Sinton E, Schlenker T, Huynh D, Hamilton F, Meldrum DR. Lower pregnancy rate with premature luteinization during pituitary suppression with leuprolide acetate. Fertil Steril 1991;55:563-566.
62. Shulman A, Ghetler Y, Beyth Y, Ben-Nun I. The significance of an early (premature) rise of plasma progesterone in in vitro fertilization cycles induced by a 'long protocol' of gonadotropin releasing hormone analogue and human menopausal gonadotropins. J Assist Reprod Genet 1996;13:207-211.
63. Silverberg KM, Burns WN, Olive DL, Riehl RM, Schenken RS. Serum progesterone levels predict success of in vitro fertilization/embryo transfer in patients stimulated with leuprolide acetate and human menopausal gonadotropins. J Clin Endocrinol Metab 1991;73:797-803.
64. Smitz J, Ron-El R, Tarlatzis BC. The use of gonadotrophin releasing hormone agonists for in vitro fertilization and other assisted procreation techniques: experience from three centres. Hum Reprod 1992;7(Suppl. 1):49-66.
65. Stouffer RL, Xu F, Duffy DM. Molecular control of ovulation and luteinization in the primate follicle. Front Biosci 2007;12:297-307.
66. Ubaldi F, Camus M, Smitz J, Bennink HC, Van Steirteghem A, Devroey P. Premature luteinization in in vitro fertilization cycles using gonadotropinreleasing hormone agonist (GnRH-a) and recombinant folliclestimulating hormone (FSH) and GnRH-a and urinary FSH. Fertil Steril 1996;66:275-280.
67. Venetis CA, Kolibianakis EM, Papanikolaou E, Bontis J, Devroey P, Tarlatzis BC. Is progesterone elevation on the day of human chorionic gonadotrophin administration associated with the probability of pregnancy in in vitro fertilization? A systematic review and meta-analysis. Hum Reprod Update 2007;13:343-355.
68. Venetis CA, Kolibianakis EM, Bosdou JK, Tarlatzis BC. Progesterone elevation and probability of pregnancy after IVF: a systematic review and meta-analysis of over 60 000 cycles. Hum Reprod Update 2013; 19:433-457.
69. Wu Z, Li R, Ma Y, Deng B, Zhang X, Meng Y, Chen X, Liu P, Qiao J. Effect of HCG-day serum progesterone and oestradiol concentrations on pregnancy outcomes in GnRH agonist cycles. Reprod Biomed Online 2012;24:511-520.
70. Xu B, Li Z, Zhang HW, Jin L, Li YF, Ai JH, Zhu GJ. Serum progesterone level effects on the outcome of in vitro fertilization in patients with different ovarian response: an analysis of more than 10,000 cycles. Fertil Steril 2012;97:1321-1327.
71. Younis JS. Elevated P level on the day of hCG administration is related to FSH dose: is it the whole truth? Hum Reprod 2011;26:498-499.
72. Younis JS, Haddad S, Matilsky M, Ben-Ami M. Premature luteinization: could it be an early manifestation of low ovarian reserve? Fertil Steril 1998; 69:461-465.
73. Younis JS, Matilsky M, Radin O, Ben-Ami M. Increased progesterone/ estradiol ratio in the late follicular phase could be related to low ovarian reserve in in vitro fertilization-embryo transfer cycles with a long gonadotropin-releasing hormone agonist. Fertil Steril 2001;76:294-299.
74. Yovel I, Yaron Y, Amit A, Peyser MR, David MP, Kogosowski A, Lessing JB. High progesterone levels adversely affect embryo quality and pregnancy rates in in vitro fertilization and oocyte donation programs. Fertil Steril 1995;64:128-131.
75. Zelinski-Wooten MB, Hess DL, Wolf DP, Stouffer RL. Steroid reduction during ovarian stimulation impairs oocyte fertilization, but not folliculogenesis, in rhesus monkeys. Fertil Steril 1994;61:1147-1155.